Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Top Story
Policy and Regulation
FDA releases LDT final rule
The FDA announced its final rule on regulating laboratory developed tests (LDTs), also saying it will adopt targeted enforcement discretion for several categories of IVD LDTs manufactured by labs.
Featured
Research Alliance
GSK, Genomics PLC collaborate on polygenic risk score use for clinical trials
COVID-19
Study: Age-related differences in nasal cells offer COVID-19 protection
Latest News
Pillar Biosciences gets FDA approval for NGS solid tumor profiling test
April 26, 2024
Immunovia announces positive results for next-gen pancreatic cancer test
April 25, 2024
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Labcorp buys Invitae portfolio for $239M
April 26, 2024
Business Insights
Pathology and AI
Quest Diagnostics to add digital pathology lab, AI pathology center in Tennessee
Policy and Regulation
FDA releases LDT final rule
Financing
Variantyx raises $36M in funding
FDA Clearance
Pillar Biosciences gets FDA approval for NGS solid tumor profiling test
Diagnostic Technologies
Policy and Regulation
FDA releases LDT final rule
FDA Clearance
Pillar Biosciences gets FDA approval for NGS solid tumor profiling test
Sequencing
Mission Bio launches new features for Tapestri platform
Gene silencing and gene editing
Engineered Cas clears barrier to antiviral CRISPR therapies
Diseases
COVID-19
Study: Age-related differences in nasal cells offer COVID-19 protection
Validation
Immunovia announces positive results for next-gen pancreatic cancer test
Collaboration
Vertex to pay $25M upfront to scale cell manufacturing technology
Point-of-Care Testing
Scout secures CARB-X grant to advance diagnostic test development
More from LabPulse.com
Quest Diagnostics to add digital pathology lab, AI pathology center in Tennessee
By
LabPulse.com staff writers
Quest Diagnostics said it will acquire PathAI Diagnostics in Memphis, TN, the business of PathAI that provides anatomic and digital pathology laboratory services, to accelerate the adoption of digital and AI pathology.
May 1, 2024
Variantyx raises $36M in funding
By
LabPulse.com staff writers
Precision molecular diagnostics firm Variantyx has raised $36 million in a recent funding round, bringing the total funding that Variantyx has raised to more than $125 million.
April 30, 2024
Bristol Myers Squibb to reduce workforce in restructuring plan
By
LabPulse.com staff writers
As part of a restructuring plan intended to cut $1.5 billion in costs, Bristol Myers Squibb plans to cut about 6% of its workforce, according to the firm.
April 25, 2024
U.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuit
By
LabPulse.com staff writers
The Patents Court of the High Court of England and Wales has ruled that two patents owned by Bio-Techne are invalid, rejecting a patent infringement lawsuit filed by Bio-Techne/ACD in the U.K. against Molecular Instruments.
April 24, 2024
Scout secures CARB-X grant to advance diagnostic test development
By
LabPulse.com staff writers
Scout, formerly Uh Oh Labs, will advance its point-of-care (POC) diagnostic test for sexually transmitted infections (STIs) with a new $1 million accelerator grant.
April 22, 2024
Mission Bio launches new features for Tapestri platform
By
Matt Limb
Mission Bio has launched new multiplexing features for its Tapestri platform, saying they will make single-cell technology more affordable and accessible to the biomedical community.
April 24, 2024
Quest adds new biomarker test to Alzheimer's portfolio
By
LabPulse.com staff writers
Quest Diagnostics has launched a new blood biomarker test as part of its AD-Detect portfolio of blood tests for Alzheimer's disease risk assessment.
April 23, 2024
Bio-Techne files EU patent infringement suit against Molecular Instruments
By
LabPulse.com staff writers
Life sciences company Bio-Techne has filed a lawsuit against Molecular Instruments in the pan-European Unified Patent Court, alleging patent infringement of its RNAscope in situ hybridization technology.
April 23, 2024
Target ALS launches new data portal for research
By
Matt Limb
A nonprofit medical research foundation has launched a data portal designed to help spur scientific breakthroughs for the disease amyotrophic lateral sclerosis (ALS).
April 23, 2024
Ipsen, Skyhawk to collaborate on drug discovery for rare neurological disorders
By
LabPulse.com staff writers
Biopharmaceutical company Ipsen and clinical-stage biopharmaceutical firm Skyhawk have signed an exclusive collaboration to discover and develop small-molecule therapeutics targeting RNA to treat rare neurological disorders.
April 22, 2024
Engineered Cas clears barrier to antiviral CRISPR therapies
By
Nick Paul Taylor
Researchers have engineered a Cas enzyme to enhance activity against RNA viruses, resulting in a system that completely blocked the replication of various SARS-CoV-2 strains.
April 19, 2024
AI-powered endoscope doubles detection of high-risk esophageal lesions
By
Nick Paul Taylor
Deep learning has doubled the detection of high-risk lesions during routine endoscopies in a clinical trial of more than 3,000 patients in China.
April 17, 2024